26 July 2013 - Deborah Wilkes
Archived
The European Medicines Agency (EMA) has recommended changes to the use of metoclopramide-containing medicines to "minimise the known risks of potentially-serious neurological side-effects".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.